Company
Diane McGuire founded PharmAcumen Consulting, Inc. to fill a gap in the virtual pharma/biotech communities. While Vice President of Technical Operations and Quality Assurance at a small pharmaceutical company, Diane struggled to find the right consultants when she needed advice on setting up supply networks, finding the right formulators, and designing the quality system for a virtual company. The controls, protocols, risk management, and regulations governing modern pharmas and biotechs are not obvious. Efficient project development requires actual experience and knowledge in the virtual space.
The company is called PharmAcumen because our hand-picked consultant network possesses the acumen or insight and ability to make fast, accurate judgments of situations in the dynamic world of pharmaceutical manufacturing.
PharmAcumen has expanded in 2023 and launched its Investor Relations Consulting arm. Our handpicked consultant was a national Institutional Investor award winner for Investor Relations.
Employees
Diane McGuire, Founder
Diane McGuire founded PharmAcumen Consulting, Inc. in 2010. Prior to that, Ms. McGuire was Vice President of Technical Operations and Quality at Oscient Pharmaceuticals from 2002 to 2010 where she built a virtual technical operations and development organization for products in Phase I to Phase III. As the company evolved to a commercial stage company, Ms. McGuire built the global virtual technical operations group and infrastructure for distribution, logistics, manufacturing, technical services and analysis. Prior to Oscient, Ms. McGuire held various management level positions at Alkermes and Eli Lilly including Plant Manager, Manager of Operations Strategy and Outsourcing and Supply Chain Head for biotechnology API. Ms. McGuire has a B.S. in Industrial Engineering from the Pennsylvania State University and an MBA from Carnegie Mellon University.
Michael McGuire, Investor Relations
Mike McGuire has more than two decades of investor relations experience. In his most recent corporate role, as senior vice president, investor relations, at CVS Health, Mr. McGuire was responsible for effectively communicating the company’s value proposition to 25 sell-side analysts and 800+ institutions and leading all messaging and communications with Wall Street. He also provided leadership to all aspects of CVS Health’s proactive and strategic investor relations program including annual analyst day, annual report development, conferences, road shows, stockholder meeting and the IR website.
In his most recent consulting role, Mr. McGuire led the investor relations function at Bath & Body Works on an interim basis,during which he was again responsible for effectively communicating the company's value proposition to the investing community.
Mr. McGuire has extensive experience in mergers & acquisitions, crisis communications and strategic and competitive analysis. Prior to joining CVS Health in 2002, McGuire held management positions in strategic planning and capital management within CVS. Mr. McGuire holds an MBA from Indiana University and a bachelor’s degree in architecture from the University of Notre Dame.
